Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients

Eye

Volumn 15, Issue 4, 2001, Pages 525-530

  Chowers, I ^a   Banin, E ^a   Merin, S ^a   Cooper, M ^a   Granot, E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Abetalipoproteinaemia; Hypobetalipoproteinaemia; Retinal degeneration; Vitamin A; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B; RETINOL;

ABETALIPOPROTEINEMIA; ADOLESCENT; ADULT; ARTICLE; ATTENUATION; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ELECTRORETINOGRAPHY; EYE FUNDUS; FEMALE; FOLLOW UP; HOMOZYGOSITY; HUMAN; HYPOBETALIPOPROTEINEMIA; MALE; MEDICAL ASSESSMENT; OPHTHALMOLOGY; OPHTHALMOSCOPY; PERIMETRY; PIGMENT EPITHELIUM; RETINA CONE; RETINA DEGENERATION; RETINA ROD; TIME; TREATMENT OUTCOME; VISUAL FIELD DEFECT; VITAMIN SUPPLEMENTATION;

EID: 0034886063     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.2001.167     Document Type: Article

References (35)

1. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa
2. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia
3. Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia
4. Cloning and gene defects in microsomal triglyercide transfer protein associated with abetalipoproteinaemia
5. Familial hypobetalipoproteinemia: Differences in lipoprotein structure and composition
6. Neuromuscular diseases that affect the eye
7. Ophthalmoplegia and dissociated nystagmus in abetalipoproteinemia
8. The neuropathy of abetalipoproteinemia
9. Neuro-ophthalmologic involvement in 2 cases of dyslipidosis
10. Angioid streaks associated with abetalipoproteinemia
11. Ocular motor signs in some metabolic diseases
12. Bassen-Kornzweig syndrome: Present status
13. The Bassen-Kornzweig syndrome: 18 years in evolution
14. Ocular abnormalities in abetalipoproteinemia A
15. Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinemia
16. Hypobetalipoproteinemia in childhood: A review
17. Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinemia
18. Electrophysiological studies of the visual system in mentally retarded children
19. Changes produced by light in the standing potential of the human eye
20. Vitamin E deficiency retinopathy in dogs
21. Retinal degeneration in monkeys induced by deficiencies of vitamin E or A
22. Deficiencies of vitamins E and A in the rat: Retinal damage and lipofuscin accumulation
23. Neurologic findings in vitamin E deficiency
24. Electroretinographic responses following vitamin A therapy in abetalipoproteinemia
25. Retinitis pigmentosa in abetalipoproteinemia: Effect of vitamin A
26. Abetalipoproteinemia with special reference to the visual defect
27. Long-term management of abetalipoproteinemia
28. Effect of large oral doses of vitamine E on the neurological sequelae of patients with abetalipoproteinemia
29. Vitamin E and neurological function
30. Electrophysiologic features of abetalipoproteinemia: Functional consequences of vitamin E deficiency
31. Abelalipoproteinaemia in adults: Role of vitamin therapy
32. Red blood cell membrane phosphatidylethanolamine fatty acid
33. Abnormal plasma lipids of patients with retinitis pigmentosa
34. Red blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosa
35. Neutral lipids of plasma and adipose tissue in abetalipoproteinema